Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax

scientific article published on 23 March 2020

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD.2019004492
P698PubMed publication ID32206772

P50authorBarbara EichhorstQ47158788
Stephan StilgenbauerQ47158807
Jasmin BahloQ108428543
P2093author name stringKarl-Anton Kreuzer
Michael Hallek
Hartmut Döhner
Lars Bullinger
Christof Schneider
Michael Kneba
Anna Dolnik
Daniel Mertens
Eugen Tausch
Can Zhang
Kirsten Fischer
Yanwen Jiang
Matthias Ritgen
Othman Al-Sawaf
Johannes Bloehdorn
Kathryn Humphrey
Sandra Robrecht
Maneesh Tandon
William Schary
Anna Maria Fink
Michele Porro Lurà
P577publication date2020-03-23
P1433published inBloodQ885070
P1476titlePrognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax

Reverse relations

cites work (P2860)
Q99557890Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Q98953060Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

Search more.